The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP)

2007 ◽  
Vol 60 (8) ◽  
pp. 952-954 ◽  
Author(s):  
G.J. McArthur ◽  
M.E. Banwell ◽  
M.G. Cook ◽  
B.W. Powell
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Malignant Potential ◽  
Uncertain Malignant Potential ◽  
Node Biopsy ◽  
Melanocytic Lesions

Melanocytic tumors of uncertain malignant potential in childhood: do we really need sentinel node biopsy?

2012 ◽  
Vol 39 (11) ◽  
pp. 1049-1051 ◽  
Author(s):  
Gerardo Ferrara ◽  
Maria Elena Errico ◽  
Vittoria Donofrio ◽  
Iris Zalaudek ◽  
Giuseppe Argenziano
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Malignant Potential ◽  
Uncertain Malignant Potential ◽  
Melanocytic Tumors ◽  
Node Biopsy

scholarly journals Role of dynamic sentinel node biopsy in carcinoma penis with or without palpable nodes

2016 ◽  
Vol 32 (1) ◽  
pp. 57 ◽  
Author(s):  
N Kathiresan ◽  
Anand Raja ◽  
KrishnaKumar Ramachandran ◽  
Shirley Sundersingh
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Node Biopsy ◽  
Carcinoma Penis ◽  
Dynamic Sentinel Node Biopsy

Role Of Ultrasound Of Axilla Prior To Sentinel Node Biopsy

2008 ◽  
Vol 34 (10) ◽  
pp. 1197
Author(s):  
Sankaran Narayanan ◽  
A. Patel ◽  
K. Walmsley ◽  
M. Fazel ◽  
M. Douek
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Node Biopsy

Routine PET and PET-CT scans in melanoma patients with positive sentinel node biopsy is of limited benefit

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 8582-8582
Author(s):  
A. Constantinidou ◽  
M. Hofman ◽  
M. O'Doherty ◽  
K. Acland ◽  
C. Healy ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Pet Scan ◽  
Positive Sentinel Node ◽  
Node Biopsy ◽  
Pet Scanning ◽  
Pet Scans

8582 Background: Positron emission tomography (PET) scanning is increasingly used for the staging and management of malignant melanoma. The role of PET as a routine procedure in patients with positive sentinel node biopsy (SNB) is not yet established. We report in the series with longest follow up outcomes of PET scans performed in patients with subclinical lymph node disease. Methods: Case notes of 29 sequential patients with melanoma of Breslow thickness greater than 1mm who had PET scans within 130 days after a positive SNB were reviewed. Four patients had a PET after the lymph node dissection (LND). Results: 2 patients (6%) had a positive PET scan neither of which was melanoma related. The first patient had a thyroid tumour confirmed with fine needle aspiration biopsy and the second patient had increased uptake in the chest wall which on verification with bone scan proved to be old trauma. 28 patients (96%) had a LND and this was positive in 5 cases (17%). With a median follow up of 23 months 21 patients remained disease free. Out of the 8 patients (27%) who presented with recurrence 2 (25%) were successfully treated with further surgery and remained in remission, 4 (50%) died, 1 (12.5%) was lost from follow-up and 1 (12.5%) is followed up in another hospital. In none of the 29 cases did the early PET scan after a positive SNB alter subsequent melanoma management. Conclusions: The role of PET scanning soon after a positive sentinel node biopsy appears to be of uncertain benefit. It is questionable whether any imaging is beneficial at this stage. The results of this review suggest that PET scanning might not be indicated for this group of patients but larger prospective studies are required to confirm this. Patients Characteristics No % Male 15 (51) Female 14 (49) Melanoma Type: Nodular 8 (27) Superficial spreading 15 (51) Other 2 (6) Unknown 4 (13) Breslow thickness: 1.0–1.9 13 (44) 2.00–3.9 14 (49) ○= 4.0 2 (6) Ulceration: Yes 3 (10) No 25 (86) Unknown 1 (3) Age Median 56 No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document